FindTrial
Sign In

To investigate the efficacy of AyuBreth - a mouth spray

Bronchodilator Effect of AyuBreth in Respiratory Tract Disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037082
Enrollment
100
Registered
2021-10-05
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J209- Acute bronchitis, unspecified

Interventions

None listed

Sponsors

Dr Prerak Shah
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with any respiratory tract complains Age: Minimum age of 16 years Males and females Able to understand requirements of the study and risks involved Able to sign a consent form. Existing diagnosis of Asthma, Bronchitis or any respiratory tract diseases by a qualified medical practitioner or PI

Exclusion criteria

Exclusion criteria: Pregnant patient Patient with life threatening disorders or conditions Is currently participating in any other clinical trial

Design outcomes

Primary

MeasureTime frame
Effectiveness of AyuBreth by evaluating the comfort in breathlessness and other respiratory tract disorders Evaluate immediate bronchodilation effect of AyuBrethTimepoint: 6 days—

Secondary

MeasureTime frame
Evaluate immediate bronchodilation effect of AyuBrethTimepoint: 6 days—

Countries

India

Contacts

Public ContactDr Prerak Shah

Ayulink Ayurveda

info@ayulink.com9426616025

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026